Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly

Figure 1

Serum asprosin levels in acromegaly patients. (a) Subjects including acromegaly and controls; (b) acromegaly patients with course ≥5 years and <5 years; (c) acromegaly patients with high GH-AUC and low GH-AUC; (d) acromegaly patients with high IGF-1 SDS and low IGF-1 SDS.

(a)

(b)

(c)

(d)